| Trial ID: | L0266 |
| Source ID: | NCT03332940
|
| Associated Drug: |
Tc 99m Tilmanocept
|
| Title: |
An Evaluation of the Safety of Intravenous Tc 99m Tilmanocept and a Comparison of Imaging With Sulfur Colloid in Subjects With and Without NASH
|
| Acronym: |
--
|
| Status: |
Completed
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Nonalcoholic Steatohepatitis|NASH - Nonalcoholic Steatohepatitis
|
| Interventions: |
Drug: Tc 99M Sulfur Colloid|Drug: Tc99m-tilmanocept
|
| Outcome Measures: |
Adverse Drug Reaction|Localization of Tc 99m tilmanocept|Localization of Tc 99m sulfur colloid|Localization Distribution Comparison
|
| Sponsor/Collaborators: |
Navidea Biopharmaceuticals
|
| Gender: |
All
|
| Age: |
18 Years and older ?? (Adult, Older Adult)
|
| Phases: |
Phase 1
|
| Enrollment: |
6
|
| Study Type: |
Interventional
|
| Study Designs: |
Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic
|
| Start Date: |
December 6, 2017
|
| Completion Date: |
March 10, 2019
|
| Results First Posted: |
--
|
| Last Update Posted: |
March 21, 2019
|
| Locations: |
Kettering Medical Center, Kettering, Ohio, United States
|
| URL: |
https://ClinicalTrials.gov/show/NCT03332940
|
